A multiplex ligase detection reaction-fluorescent microsphere assay for simultaneous detection of single nucleotide polymorphisms associated with Plasmodium falciparum drug resistance

Journal of Clinical Microbiology

Volumn 45, Issue 3, 2007, Pages 752-761

  Carnevale, Eric P ^a   Kouri, Drew ^a   DaRe, Jeana T ^a   McNamara, David T ^a   Mueller, Ivo ^b   Zimmerman, Peter A ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PAPUA NEW GUINEA INSTITUTE OF MEDICAL RESEARCH   (Papua New Guinea)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; FANSIDAR;

ADULT; ALLELE; ARTICLE; ASSAY; DHFR GENE; DHPS GENE; DRUG EFFICACY; ENDEMIC DISEASE; GENE; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; MALARIA; MULTIPLEX LIGASE DETECTION REACTION FLUORESCENT MICROSPHERE ASSAY; NONHUMAN; PAPUA NEW GUINEA; PFCRT GENE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; ANTIMALARIALS; CHLOROQUINE; DIHYDROPTEROATE SYNTHASE; DRUG COMBINATIONS; DRUG RESISTANCE; FLUORESCENCE; HUMANS; LIGASES; MALARIA, FALCIPARUM; MEMBRANE TRANSPORT PROTEINS; MICROSPHERES; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTOZOAN PROTEINS; PYRIMETHAMINE; SULFADOXINE; TETRAHYDROFOLATE DEHYDROGENASE;

PLASMODIUM FALCIPARUM;

EID: 33947263776     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01683-06     Document Type: Article

References (37)

1. Ahmed, A., D. Bararia, S. Vinayak, M. Yameen, S. Biswas, V. Dev, A. Kumar, M. A. Ansari, and Y. D. Sharma. 2004. Plasmodium falciparum isolates in India exhibit a progressive increase in mutations associated with sulfadoxine-pyrimethamine resistance. Antimicrob. Agents Chemother. 48:879-889.
2. Alifrangis, M., S. Enosse, R. Pearce, C. Drakeley, C. Roper, I. F. Khalil, W. M. Nkya, A. M. Ronn, T. G. Theander, and I. C. Bygbjerg. 2005. A simple, high-throughput method to detect Plasmodium falciparum single nucleotide polymorphisms in the dihydrofolate reductase, dihydropteroate synthase, and P. falciparum chloroquine resistance transporter genes using polymerase chain reaction- and enzyme-linked immunosorbent assay-based technology. Am. J. Trop. Med. Hyg. 72:155-162.
3. Attaran, A., K. I. Barnes, C. Curtis, U. d'Alessandro, C. I. Fanello, M. R. Galinski, G. Kokwaro, S. Looareesuwan, M. Makanga, T. K. Mutabingwa, A. Talisuna, J. F. Trape, and W. M. Watkins. 2004. WHO, the Global Fund, and medical malpractice in malaria treatment. Lancet 363:237-240.
4. Biswas, S., A. Escalante, S. Chaiyaroj, P. Angkasekwinai, and A. A. Lal. 2000. Prevalence of point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum isolates from India and Thailand: a molecular epidemiologic study. Trop. Med. Int. Health 5:737-743.
5. Brooks, D. R., P. Wang, M. Read, W. M. Watkins, P. F. Sims, and J. E. Hyde. 1994. Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine. Eur. J. Biochem. 224:397-405.
6. Casey, G. J., M. Ginny, M. Uranoli, I. Mueller, J. C. Reeder, B. Genton, and A. F. Cowman. 2004. Molecular analysis of Plasmodium falciparum from drug treatment failure patients in Papua New Guinea. Am. J. Trop. Med. Hyg. 70:251-255.
7. Cowman, A. F., M. J. Morry, B. A. Biggs, G. A. Cross, and S. J. Foote. 1988. Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 85:9109-9113.
8. Doumbo, O. K., K. Kayentao, A. Djimde, J. F. Cortese, Y. Diourte, A. Konare, J. G. Kublin, and C. V. Plowe. 2000. Rapid selection of Plasmodium falciparum dihydrofolate reductase mutants by pyrimethamine prophylaxis. J. Infect. Dis. 182:993-996.
9. Duraisingh, M. T., J. Curtis, and D. C. Warhurst. 1998. Plasmodium falciparum: detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion. Exp. Parasitol. 89:1-8.
10. Fidock, D. A., T. Nomura, A. K. Talley, R. A. Cooper, S. M. Dzekunov, M. T. Ferdig, L. M. Ursos, A. B. Sidhu, B. Naude, K. W. Deitsch, X. Z. Su, J. C. Wootton, P. D. Roepe, and T. E. Wellems. 2000. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol. Cell 6:861-871.
11. Genton, B., F. al-Yaman, H. P. Beck, J. Hii, S. Mellor, A. Narara, N. Gibson, T. Smith, and M. P. Alpers. 1995. The epidemiology of malaria in the Wosera area, East Sepik Province, Papua New Guinea, in preparation for vaccine trials. I. Malariometric indices and immunity. Ann. Trop. Med. Parasitol. 89:359-376.
12. Genton, B., F. al-Yaman, H. P. Beck, J. Hii, S. Mellor, L. Rare, M. Ginny, T. Smith, and M. P. Alpers. 1995. The epidemiology of malaria in the Wosera area, East Sepik Province, Papua New Guinea, in preparation for vaccine trials. II. Mortality and morbidity. Ann. Trop. Med. Parasitol. 89:377-390.
13. Hapuarachchi, H. C., M. Y. Dayanath, K. B. Bandara, S. Abeysundara, W. Abeyewickreme, N. R. de Silva, S. Y. Hunt, and C. H. Sibley. 2006. Point mutations in the dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum and resistance to sulfadoxine-pyrimethamine in Sri Lanka. Am. J. Trop. Med. Hyg. 74:198-204.
14. Kasehagen, L. J., I. Mueller, D. T. McNamara, M. J. Bockarie, B. Kiniboro, L. Rare, K. Lorry, W. Kastens, J. C. Reeder, J. W. Kazura, and P. A. Zimmerman. 2006. Changing patterns of Plasmodium blood-stage infections in the Wosera region of Papua New Guinea monitored by light microscopy and high through-put PCR diagnosis. Am. J. Trop. Med. Hyg. 75:588-596.
15. Kublin, J. G., F. K. Dzinjalamala, D. D. Kamwendo, E. M. Malkin, J. F. Cortese, L. M. Martino, R. A. Mukadam, S. J. Rogerson, A. G. Lescano, M. E. Molyneux, P. A. Winstanley, P. Chimpeni, T. E. Taylor, and C. V. Plowe. 2002. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. J. Infect. Dis. 185:380-388.
16. Marfurt, J., I. Müller, A. Sie, P. Maku, M. Goroti, J. Reeder, H. P. Beck, and B. Genton. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against falciparum and vivax malaria in Papua New Guinea. Am. J. Trop. Med. Hyg., in press.
17. McNamara, D. T., L. J. Kasehagen, B. T. Grimberg, J. Cole-Tobian, W. E. Collins, and P. A. Zimmerman. 2006. Diagnosing infection levels of four human malaria parasite species by a polymerase chain reaction/ligase detection reaction fluorescent microsphere-based assay. Am. J. Trop. Med. Hyg. 74:413-421.
18. Mehlotra, R. K., H. Fujioka, P. D. Roepe, O. Janneh, L. M. Ursos, V. Jacobs-Lorena, D. T. McNamara, M. J. Bockarie, J. W. Kazura, D. E. Kyle, D. A. Fidock, and P. A. Zimmerman. 2001. Evolution of a unique Plasmodium falciparum chloroquine-resistance phenotype in association with pfcrt polymorphism in Papua New Guinea and South America. Proc. Natl. Acad. Sci. USA 98: 12689-12694.
19. Mehlotra, R. K., L. J. Kasehagen, M. Baisor, K. Lorry, J. W. Kazura, M. J. Bockarie, and P. A. Zimmerman. 2002. Malaria infections are randomly distributed in diverse holoendemic areas of Papua New Guinea. Am. J. Trop. Med. Hyg. 67:555-562.
20. Mita, T., A. Kaneko, I. Hwaihwanje, T. Tsukahara, N. Takahashi, H. Osawa, K. Tanabe, T. Kobayakawa, and A. Bjorkman. 2006. Rapid selection of dhfr mutant allele in Plasmodium falciparum isolates after the introduction of sulfadoxine/pyrimethamine in combination with 4-aminoquinolines in Papua New Guinea. Infect. Genet. Evol. 6:447-452.
21. Nzila, A. M., E. K. Mberu, J. Sulo, H. Dayo, P. A. Winstanley, C. H. Sibley, and W. M. Watkins. 2000. Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasites. Antimicrob. Agents Chemother. 44:991-996.
22. Nzila-Mounda, A., E. K. Mberu, C. H. Sibley, C. V. Plowe, P. A. Winstanley, and W. M. Watkins. 1998. Kenyan Plasmodium falciparum field isolates: correlation between pyrimethamine and chlorcycloguanil activity in vitro and point mutations in the dihydrofolate reductase domain. Antimicrob. Agents Chemother. 42:164-169.
23. Peterson, D. S., W. K. Milhous, and T. E. Wellems. 1990. Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria. Proc. Natl. Acad. Sci. USA 87:3018-3022.
24. Peterson, D. S., D. Walliker, and T. E. Wellems. 1988. Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proc. Natl. Acad. Sci. USA 85: 9114-9118.
25. Plowe, C. V., J. F. Cortese, A. Djimde, O. C. Nwanyanwu, W. M. Watkins, P. A. Winstanley, J. G. Estrada-Franco, R. E. Mollinedo, J. C. Avila, J. L. Cespedes, D. Carter, and O. K. Doumbo. 1997. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance. J. Infect. Dis. 176:1590-1596.
26. Reeder, J. C., K. H. Rieckmann, B. Genton, K. Lorry, B. Wines, and A. F. Cowman. 1996. Point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes and in vitro susceptibility to pyrimethamine and cycloguanil of Plasmodium falciparum isolates from Papua New Guinea. Am. J. Trop. Med. Hyg. 55:209-213.
27. Sibley, C. H., and P. Ringwald. 2006. A database of antimalarial drug resistance. Malar. J. 5:48.
28. Talisuna, A. O., A. Nalunkuma-Kazibwe, P. Langi, T. K. Mutabingwa, W. W. Watkins, E. Van Marck, T. G. Egwang, and U. D'Alessandro. 2004. Two mutations in dihydrofolate reductase combined with one in the dihydropteroate synthase gene predict sulphadoxine-pyrimethamine parasitological failure in Ugandan children with uncomplicated falciparum malaria. Infect. Genet. Evol. 4:321-327.
29. Trape, J. F. 2001. The public health impact of chloroquine resistance in Africa. Am. J. Trop. Med. Hyg. 64:12-17.
30. Triglia, T., and A. F. Cowman. 1999. The mechanism of resistance to sulfa drugs in Plasmodium falciparum. Drug Resist. Updat. 2:15-19.
31. Triglia, T., and A. F. Cowman. 1994. Primary structure and expression of the dihydropteroate synthetase gene of Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 91:7149-7153.
32. Triglia, T., J. G. Menting, C. Wilson, and A. F. Cowman. 1997. Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 94:13944-13949.
33. Veiga, M. I., P. E. Ferreira, A. Bjorkman, and J. P. Gil. 2006. Multiplex PCR-RFLP methods for pfcrt, pfmdr1 and pfdhfr mutations in Plasmodium falciparum. Mol. Cell. Probes 20:100-104.
34. Walliker, D., I. A. Quakyi, T. E. Wellems, T. F. McCutchan, A. Szarfman, W. T. London, L. M. Corcoran, T. R. Burkot, and R. Carter. 1987. Genetic analysis of the human malaria parasite Plasmodium falciparum. Science 236:1661-1666.
35. Wellems, T. E., A. Walker-Jonah, and L. J. Panton. 1991. Genetic mapping of the chloroquine-resistance locus on Plasmodium falciparum chromosome 7. Proc. Natl. Acad. Sci. USA 88:3382-3386.
36. Wilairatana, P., D. E. Kyle, S. Looareesuwan, K. Chinwongprom, S. Amradee, N. J. White, and W. M. Watkins. 1997. Poor efficacy of antimalarial biguanide-dapsone combinations in the treatment of acute, uncomplicated, falciparum malaria in Thailand. Ann. Trop. Med. Parasitol. 91:125-132.
37. Zimmerman, P. A., A. Buckler-White, G. Alkhatib, T. Spalding, J. Kubofcik, C. Combadiere, D. Weissman, O. Cohen, A. Rubbert, G. Lam, M. Vaccarezza, P. E. Kennedy, V. Kumaraswami, J. V. Giorgi, R. Detels, J. Hunter, M. Chopek, E. A. Berger, A. S. Fauci, T. B. Nutman, and P. M. Murphy. 1997. Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk. Mol. Med. 3:23-36.